I-Mab Biopharma (IMAB) Earnings
|
Expand Research on IMAB
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -13.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/13/25  |
Q325 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/20/25 |
Q225 | -$0.07 | -$0.04 | -$0.03 | N/A | N/A | N/A |  | | Details | |
| 5/28/25 |
Q125 | N/A | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/31/25 |
Q424 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/28/25 |
Q424 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/26/25 |
Q424 | N/A | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/14/24 |
Q324 | -$0.11 | -$0.07 | -$0.04 | N/A | N/A | N/A | | | Details | |
| 8/28/24 | Q224 | -$0.09 | -$0.31 | +$0.22 | N/A | $750K | N/A | | | Details |
